Revenues in USD of PLUS THERAPEUTICS, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
PLUS THERAPEUTICS, INC. quarterly/annual Revenues history and change rate from Q2 2010 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Revenues for the quarter ending 30 Sep 2025 was $1.4M, a 4.05% decline year-over-year.
  • PLUS THERAPEUTICS, INC. Revenues for the twelve months ending 30 Sep 2025 was $5.26M.
  • PLUS THERAPEUTICS, INC. annual Revenues for 2024 was $5.82M, a 18.5% increase from 2023.
  • PLUS THERAPEUTICS, INC. annual Revenues for 2023 was $4.91M.
  • PLUS THERAPEUTICS, INC. annual Revenues for 2017 was $2.69M, a 42.2% decline from 2016.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

PLUS THERAPEUTICS, INC. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $5.26M $1.4M -$59K -4.05% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $5.32M $1.39M +$111K +8.68% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $5.21M $1.06M -$618K -36.9% 01 Jan 2025 31 Mar 2025 10-Q 30 May 2025
Q4 2024 $5.82M $1.41M 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $1.46M 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $1.28M 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $1.68M 01 Jan 2024 31 Mar 2024 10-Q 30 May 2025
Q2 2018 $2.52M $660K -$309K -31.9% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 $2.83M $731K +$140K +23.7% 01 Jan 2018 31 Mar 2018 10-Q 11 May 2018
Q4 2017 $2.69M $662K -$804K -54.8% 01 Oct 2017 31 Dec 2017 10-K 09 Mar 2018
Q3 2017 $3.49M $467K -$264K -36.1% 01 Jul 2017 30 Sep 2017 10-K 09 Mar 2018
Q2 2017 $3.76M $969K -$157K -13.9% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 $3.91M $591K -$742K -55.7% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q4 2016 $4.66M $1.47M -$90K -5.78% 01 Oct 2016 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 $4.75M $731K -$35K -4.57% 01 Jul 2016 30 Sep 2016 10-K 09 Mar 2018
Q2 2016 $4.78M $1.13M -$488K -30.2% 01 Apr 2016 30 Jun 2016 10-K 09 Mar 2018
Q1 2016 $5.27M $1.33M +$431K +47.8% 01 Jan 2016 31 Mar 2016 10-K 09 Mar 2018
Q4 2015 $4.84M $1.56M -$913K -37% 01 Oct 2015 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 $5.75M $766K +$248K +47.9% 01 Jul 2015 30 Sep 2015 10-K 24 Mar 2017
Q2 2015 $5.5M $1.61M +$679K +72.6% 01 Apr 2015 30 Jun 2015 10-K 24 Mar 2017
Q1 2015 $4.82M $902K -$129K -12.5% 01 Jan 2015 31 Mar 2015 10-K 24 Mar 2017
Q4 2014 $4.95M $2.47M -$237K -8.76% 01 Oct 2014 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 $5.19M $518K -$1.1M -67.9% 01 Jul 2014 30 Sep 2014 10-K 11 Mar 2016
Q2 2014 $6.29M $935K -$473K -33.6% 01 Apr 2014 30 Jun 2014 10-K 11 Mar 2016
Q1 2014 $6.76M $1.03M -$361K -25.9% 01 Jan 2014 31 Mar 2014 10-K 11 Mar 2016
Q4 2013 $7.12M $2.71M -$1.26M -31.8% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 $8.38M $1.62M +$302K +23% 01 Jul 2013 30 Sep 2013 10-K 16 Mar 2015
Q2 2013 $8.08M $1.41M -$539K -27.7% 01 Apr 2013 30 Jun 2013 10-K 16 Mar 2015
Q1 2013 $8.62M $1.39M -$89K -6.01% 01 Jan 2013 31 Mar 2013 10-K 16 Mar 2015
Q4 2012 $8.71M $3.97M +$1.89M +91.1% 01 Oct 2012 31 Dec 2012 10-K 14 Mar 2014
Q3 2012 $6.82M $1.31M -$820K -38.4% 01 Jul 2012 30 Sep 2012 10-K 14 Mar 2014
Q2 2012 $7.64M $1.95M -$464K -19.2% 01 Apr 2012 30 Jun 2012 10-K 14 Mar 2014
Q1 2012 $8.1M $1.48M +$119K +8.74% 01 Jan 2012 31 Mar 2012 10-K 14 Mar 2014
Q4 2011 $7.98M $2.08M 01 Oct 2011 31 Dec 2011 10-K 15 Mar 2013
Q3 2011 $2.13M +$615K +40.5% 01 Jul 2011 30 Sep 2011 10-K 15 Mar 2013
Q2 2011 $2.41M +$320K +15.3% 01 Apr 2011 30 Jun 2011 10-K 15 Mar 2013
Q1 2011 $1.36M 01 Jan 2011 31 Mar 2011 10-K 15 Mar 2013
Q3 2010 $1.52M 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011
Q2 2010 $2.09M 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011

PLUS THERAPEUTICS, INC. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.82M +$911K +18.5% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $4.91M 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2017 $2.69M -$1.97M -42.2% 01 Jan 2017 31 Dec 2017 10-K 09 Mar 2018
2016 $4.66M -$182K -3.76% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2018
2015 $4.84M -$115K -2.32% 01 Jan 2015 31 Dec 2015 10-K 24 Mar 2017
2014 $4.95M -$2.17M -30.5% 01 Jan 2014 31 Dec 2014 10-K 11 Mar 2016
2013 $7.12M -$1.59M -18.2% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016
2012 $8.71M +$726K +9.09% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 $7.98M -$271K -3.28% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 $8.25M 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.